目的: 探讨对DRG组再细分,为制定更加合理的分组提供参考。方法: 选取湖北省十堰市某三甲综合医院和另一家二级综合医院2019—2023年消化道内镜治疗GJ1、GK1、GK2和GK3组四个ADRG组的病例;采用非参数检验和多重线性回归分析病例费用影响因素,采用决策树模型进行ADRG组的再细分,并将细分结果与国家医保局DRG2.0版分组结果比较;选取“胃和十二指肠息肉”病例,将本研究细分组结果与国家医保局DIP2.0分组结果比较。结果: 消化道内镜治疗病例分为12个DRG细分组,细分后RIV值上升,CV值下降;“胃和十二指肠息肉”病例按本研究细分组与按DIP2.0分组比较,本研究RIV值为0.4610,DIP2.0分组RIV值为0.4725,且后者的CV值普遍高于本研究结果。结论: 对消化道内镜治疗病例,在DRG分组基础上,可以以病例的主要操作类型进行再次细分,细分后组内费用集中,组间费用差异大,与DIP2.0分组方案相比,分组效能相当。本研究的分组策略能够为优化医保支付方式提供思路。
Abstract
Objective: The paper explores the subdivision of DRG, providing references for the development of more reasonable grouping. Methods: Cases in four ADRG, GJ1, GK1, GK2, and GK3, of gastrointestinal endoscopic treatment in one first-class Grade-A general hospital and one second-class general hospital in Hubei Province were selected from 2019 to 2023. The influencing factors for the cost of cases were analyzed by nonparametric tests and multiple linear regression, the decision tree model was used to subdivide the ADRG, and then the subdivision results was compared with the National Healthcare Security Administration DRG 2.0 grouping results. The cases of "gastric and duodenal polyps" were selected and divided according to the subdivision scheme of this study and the National Healthcare Security Administration DIP 2.0, respectively. The grouping results of the two were compared. Results: The cases of gastrointestinal endoscopy treatment were subdivided into 12 DRG, the RIV increased, and the CV decreased. The results of the subdivision group in this study and the DIP2.0 in terms of the cases of "gastric and duodenal polyps" was compared. The RIV of this study was 0.4610, the RIV of DIP 2.0 was 0.4725, and the CV of the latter was generally higher than that of the results of the present study. Conclusion: For gastrointestinal endoscopy treatment cases, they can be subdivided again by the main operation type of the cases based on DRG. After the subdivision, the difference in expenses is not significant within a group, and there are significant differences in expenses between groups. Compared with DIP 2.0, this subgroup is equally effective. The grouping strategy of this study can provide ideas for optimizing medical insurance payment methods.
关键词
消化系统 /
内镜治疗 /
DRG /
DIP
Key words
digestive system /
endoscopic treatment /
DRG /
DIP
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 高月霞,许琼琼,肖静,等.基于回归树模型的肝癌住院费用病例组合研究[J].中国卫生统计,2017,34(5):726-728.
[2] 王亦冬,孙志楠,陈颖.典型国家DRG研究与实践进展综述及其对我国的启示[J].中国卫生经济,2021,40(6):91-96.
[3] 任雨青,李伟,朱辰轩,等.肿瘤内科DRG分组细化的地方实践研究[J].卫生经济研究,2024,41(6):19-22+26.
[4] 程文炜,常维夫.DRG支付制度中低码高编行为实证分析研究[J].中国医疗保险,2022(9):11-15.
[5] 池旎,涂晓贤,连晓岚.基于决策树模型的急性髓系白血病DRG分组研究[J].中华医院管理杂志,2023,39(2):97-101.
[6] 倪志颖,臧召燕,张博锴,等.DRG支付对急性胰腺炎患者住院费用影响分析[J].中国医疗保险,2024(4):103-107.
[7] 王德礼,窦水儿,徐益祥,等.DIP付费下医保患者住院费用结构变动分析[J].中国医疗保险,2024(4):108-112.
[8] 张钰璐,王瑞宇,何俊曦,等.脑卒中错误编码对DRG分组的影响[J].中国病案,2023,24(5):10-13.
[9] 王立琴.住院病案首页主要诊断编码的选择对DRG分组的影响[J].江苏卫生事业管理,2023,34(9):1237-1238+1249.
[10] 张亚楠,刘玲,孙建勋.肺恶性肿瘤内科诊断组DRG分组方案研究[J].中国医疗保险,2024(9):79-84.
[11] 廖藏宜.DRG/DIP付费的高编高套问题思辨[J].中国卫生,2023(10):65-66.
[12] 高峰,郑二维,张清芝,等.基于决策树模型脑卒中患者住院费用DRG分组实证研究[J].中国卫生经济,2020,39(4):33-35.
[13] 王川,陈琳,宋振,等.DRGs模式和决策树组合模型在血液病患者住院费用研究中的应用[J].中国卫生统计,2020,37(1):70-72.
基金
国家卫生健康委医院管理研究所“公立医院精细化管理与评价研究项目”(N1HA23JXH079); 2023年度湖北省教育厅哲学社会科学研究项目“基于诊疗知识价值的按疾病诊断相关分组付费机制优化研究”(23Y150)